e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Cystic fibrosis (adults and children): risk factors and clinical problems
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Early deaths in cystic fibrosis: Analysis of causes and risk factors in a pediatric cohort
L.L. Dracea, L. Pop (Brasov, Timisoara, Romania)
Source:
Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Session:
Cystic fibrosis (adults and children): risk factors and clinical problems
Session type:
Thematic Poster Session
Number:
1112
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L.L. Dracea, L. Pop (Brasov, Timisoara, Romania). Early deaths in cystic fibrosis: Analysis of causes and risk factors in a pediatric cohort. Eur Respir J 2012; 40: Suppl. 56, 1112
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Risk factors for lung disease progression in children with cystic fibrosis; a longitudinal cohort study
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017
Impact of other risk factors than age at diagnosis on outcome in cystic fibrosis patients
Source: Eur Respir J 2006; 28: Suppl. 50, 715s
Year: 2006
Risk factors for lung disease progression in children with cystic fibrosis
Source: Eur Respir J, 51 (6) 1702509; 10.1183/13993003.02509-2017
Year: 2018
Risk factors for lung disease progression in children with cystic fibrosis
Source: Eur Respir J, 52 (4) 1801492; 10.1183/13993003.01492-2018
Year: 2018
Risk factors for progression of cystic fibrosis lung disease from childhood to adulthood
Source: Virtual Congress 2020 – Respiratory diseases in children and adults
Year: 2020
Risk of cardiovascular comorbidities in patients with idiopathic pulmonary fibrosis: Analysis of Medicare data
Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption
Year: 2016
Risk factors for early lung function decline in young children with Cystic Fibrosis
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018
Epidemiology and factors associated with overweight in adults with cystic fibrosis: an Italian multicenter experience.
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020
Analysis of causes of death and mortality risk factors in elderly patients hospitalized due to pneumonia
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018
Risk factors for postoperative acute exacerbation of interstitial lung diseases: a matched case-control study
Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives
Year: 2019
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
Source: Eur Respir J 2011; 37: 356
Year: 2011
Predictor factors of mortality in patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018
Potential risk factors for poor outcomes post-lung transplant for cystic fibrosis
Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Year: 2019
Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort
Source: Eur Respir J, 55 (4) 1901694; 10.1183/13993003.01694-2019
Year: 2020
Risk factors predicting mortality in patients with lung abscess
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe
Source: ERJ Open Res, 7 (4) 00411-2021; 10.1183/23120541.00411-2021
Year: 2021
Early determinants of lung disease in children with cystic fibrosis
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020
Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study
Source: Eur Respir J, 58 (3) 2002288; 10.1183/13993003.02288-2020
Year: 2021
Screening for cystic fibrosis among high risk group patients with chronic lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 340s
Year: 2002
Oral health and some risk factors in children with cystic fibrosis
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept